BNP Paribas Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.5M | Buy |
|
|||||
|
2025
Q1 | $20.5M | Buy |
|
|||||
|
2024
Q4 | $29.5M | Buy |
|
|||||
|
2024
Q3 | $25.1M | Sell |
|
|||||
|
2024
Q2 | $24.5M | Buy |
|
|||||
|
2024
Q1 | $25.4M | Sell |
|
|||||
|
2023
Q4 | $23.4M | Buy |
|
|||||
|
2023
Q3 | $18.8M | Sell |
|
|||||
|
2023
Q2 | $11.6M | Sell |
|
|||||
|
2023
Q1 | $11.1M | Buy |
|
|||||
|
2022
Q4 | $11.2M | Buy |
|
|||||
|
2022
Q3 | $8.94M | Buy |
|